These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 39159391)

  • 41. The Short-Chain Fatty Acids Propionate and Butyrate Augment Adherent-Invasive Escherichia coli Virulence but Repress Inflammation in a Human Intestinal Enteroid Model of Infection.
    Pace F; Rudolph SE; Chen Y; Bao B; Kaplan DL; Watnick PI
    Microbiol Spectr; 2021 Oct; 9(2):e0136921. PubMed ID: 34612688
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function.
    Kelly CJ; Zheng L; Campbell EL; Saeedi B; Scholz CC; Bayless AJ; Wilson KE; Glover LE; Kominsky DJ; Magnuson A; Weir TL; Ehrentraut SF; Pickel C; Kuhn KA; Lanis JM; Nguyen V; Taylor CT; Colgan SP
    Cell Host Microbe; 2015 May; 17(5):662-71. PubMed ID: 25865369
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exploring the Molecular Mechanisms Underlying the Protective Effects of Microbial SCFAs on Intestinal Tolerance and Food Allergy.
    Luu M; Monning H; Visekruna A
    Front Immunol; 2020; 11():1225. PubMed ID: 32612610
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).
    Ratajczak W; Rył A; Mizerski A; Walczakiewicz K; Sipak O; Laszczyńska M
    Acta Biochim Pol; 2019 Mar; 66(1):1-12. PubMed ID: 30831575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The long-term consequences of antibiotic therapy: Role of colonic short-chain fatty acids (SCFA) system and intestinal barrier integrity.
    Holota Y; Dovbynchuk T; Kaji I; Vareniuk I; Dzyubenko N; Chervinska T; Zakordonets L; Stetska V; Ostapchenko L; Serhiychuk T; Tolstanova G
    PLoS One; 2019; 14(8):e0220642. PubMed ID: 31437166
    [TBL] [Abstract][Full Text] [Related]  

  • 46.
    Rogers AWL; Tsolis RM; Bäumler AJ
    Microbiol Mol Biol Rev; 2021 Feb; 85(1):. PubMed ID: 33361269
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Review article: the role of butyrate on colonic function.
    Hamer HM; Jonkers D; Venema K; Vanhoutvin S; Troost FJ; Brummer RJ
    Aliment Pharmacol Ther; 2008 Jan; 27(2):104-19. PubMed ID: 17973645
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gut microbiota and butyrate contribute to nonalcoholic fatty liver disease in premenopause due to estrogen deficiency.
    Liu L; Fu Q; Li T; Shao K; Zhu X; Cong Y; Zhao X
    PLoS One; 2022; 17(2):e0262855. PubMed ID: 35108315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Crosstalk between hypoxia-inducible factor-1α and short-chain fatty acids in inflammatory bowel disease: key clues toward unraveling the mystery.
    Xiao J; Guo X; Wang Z
    Front Immunol; 2024; 15():1385907. PubMed ID: 38605960
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolism of short-chain fatty acids by rat colonic mucosa in vivo.
    Fitch MD; Fleming SE
    Am J Physiol; 1999 Jul; 277(1):G31-40. PubMed ID: 10409148
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rationale for the luminal provision of butyrate in intestinal diseases.
    Wächtershäuser A; Stein J
    Eur J Nutr; 2000 Aug; 39(4):164-71. PubMed ID: 11079736
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of banana powder (Musa acuminata Colla) on the composition of human fecal microbiota and metabolic output using in vitro fermentation.
    Tian DD; Xu XQ; Peng Q; Zhang YW; Zhang PB; Qiao Y; Shi B
    J Food Sci; 2020 Aug; 85(8):2554-2564. PubMed ID: 32677055
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study.
    Boets E; Gomand SV; Deroover L; Preston T; Vermeulen K; De Preter V; Hamer HM; Van den Mooter G; De Vuyst L; Courtin CM; Annaert P; Delcour JA; Verbeke KA
    J Physiol; 2017 Jan; 595(2):541-555. PubMed ID: 27510655
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SCFA: mechanisms and functional importance in the gut.
    Martin-Gallausiaux C; Marinelli L; Blottière HM; Larraufie P; Lapaque N
    Proc Nutr Soc; 2021 Feb; 80(1):37-49. PubMed ID: 32238208
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dietary fructose-induced gut dysbiosis promotes mouse hippocampal neuroinflammation: a benefit of short-chain fatty acids.
    Li JM; Yu R; Zhang LP; Wen SY; Wang SJ; Zhang XY; Xu Q; Kong LD
    Microbiome; 2019 Jun; 7(1):98. PubMed ID: 31255176
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prophylactic and therapeutic supplementation using fructo-oligosaccharide improves the intestinal homeostasis after mucositis induced by 5- fluorouracil.
    Carvalho PLA; Andrade MER; Trindade LM; Leocádio PCL; Alvarez-Leite JI; Dos Reis DC; Cassali GD; Souza E Melo ÉLS; Dos Santos Martins F; Fernandes SOA; Gouveia Peluzio MDC; Generoso SV; Cardoso VN
    Biomed Pharmacother; 2021 Jan; 133():111012. PubMed ID: 33254017
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oxygen battle in the gut: Hypoxia and hypoxia-inducible factors in metabolic and inflammatory responses in the intestine.
    Singhal R; Shah YM
    J Biol Chem; 2020 Jul; 295(30):10493-10505. PubMed ID: 32503843
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microbial Regulation of Host Physiology by Short-chain Fatty Acids.
    van der Hee B; Wells JM
    Trends Microbiol; 2021 Aug; 29(8):700-712. PubMed ID: 33674141
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and Atherosclerosis?
    Ohira H; Tsutsui W; Fujioka Y
    J Atheroscler Thromb; 2017 Jul; 24(7):660-672. PubMed ID: 28552897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microbiota-derived short-chain fatty acids and modulation of host-derived peptides formation: Focused on host defense peptides.
    Liu T; Sun Z; Yang Z; Qiao X
    Biomed Pharmacother; 2023 Jun; 162():114586. PubMed ID: 36989711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.